Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FEI announces changes to Equine Prohibited Substances List
FEI Bureau has approved the changes proposed by the FEI List Group

The Fédération Equestre Internationale (FEI) Bureau has approved changes to the Equine Prohibited Substances List proposed by its List Group. The new prohibited substances list will come into effect on January 1, 2014.

Previously unlisted Metformin, a potent but legitimate oral anti-diabetic drug with a potential welfare risk, has been added to the Controlled Medication list.

Levothyroxine, an exogenous thyroid hormone replacement that could enhance performance, has also been added to the Controlled Medication list after having been unlisted.

Adrenocortico-trophic hormone (ACTH) will be moved from Banned Substances to the Controlled Medication section for the 2014 list, due to its therapeutic value in equine medicine.

Three previously unlisted substances will be added to the Banned Substances section of the 2014 list .

Ammonium Chloride injectable, Gamma Butyrolactone (GBL) and Gamma-Hydroxybutyrate (GHB) are considered to have the potential for abuse to improve athletic performance.

The approved changes to the list are also accessible on the FEI Clean Sport webpage.

The FEI Equine Prohibited Substances Database will be amended and the complete 2014 list will be made available on the Clean Sport website prior to January 1, 2014.

Conforming with FEI rules, all changes to the list are published 90 days prior to implementation to allow National Federations, athletes and veterinarians sufficient time to familiarise themselves with the revised list.

 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk